Inventor

BLAKE JAMES F

US98 patents

⚠️ This page may combine multiple inventors who share the name “BLAKE JAMES F”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BLAKE JAMES F

ARRAY BIOPHARMA INC

2-aryl- and 2-heteroaryl-substituted 2-pyridazin-3(2H)-one compounds as inhibitors of FGFR tyrosine kinases

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Serine/threonine kinase inhibitors

Pyrimidyl cyclopentanes as AKT protein kinase inhibitors

Substituted pyrazolo[1,5-a]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Pyrrolopyridines as kinase inhibitors

Pyrrolopyridines as kinase inhibitors

Pyrrolopyridines as kinase inhibitors

Pyrrolopyridines as kinase inhibitors

Pyrazolopyridines as kinase inhibitors

Method of treating inflammatory diseases

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

Hydroxylated and methoxylated pyrimidyl cyclopentanes as Akt protein kinase inhibitors

Serine/threonine kinase inhibitors

Pyrimidyl cyclopentanes as AKT protein kinase inhibitors

Heterobicyclic thiophene compounds and methods of use

Heterobicyclic pyrazole compounds and methods of use

Macrocylic compounds as ROS1 kinase inhibitors

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors

MIRATI THERAPEUTICS INC

KRas G12C inhibitors

KRas G12C inhibitors

KRAS G12C inhibitors

KRas G12D inhibitors

KRas G12C inhibitors

MITCHELL IAN S

Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors

Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors

Pyrimidyl cyclopentanes as AKT protein kinase inhibitors

Dihydrofuro pyrimidines as AKT protein kinase inhibitors

BLAKE JAMES F

Heterocyclic inhibitors of MEK and methods of use

Heterocyclic inhibitors of MEK and methods of use thereof

Heterocyclic inhibitors of MEK and methods of use thereof

LE HUEROU YVAN

Pyrrolopyridines as kinase inhibitors

Pyrrolopyridines as kinase inhibitors

LOXO ONCOLOGY INC

Point mutations in TRK inhibitor-resistant cancer and methods relating to the same

Point mutations in TRK inhibitor-resistant cancer and methods relating to the same

BANKA ANNA L

Pyrimidyl cyclopentanes as Akt protein kinase inhibitors

PFIZER

Biaryl compounds useful as anticancer agents

ALLEN SHELLEY

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

ROCHE PALO ALTO LLC

1,1-dioxo-1H-1Λ6-benzo[d]isothiazol-3-yl)-4-hydroxy-1,5-dihydro-pyrrol-2-one inhibitors of HCV polymerase

BENCSIK JOSEF

Pyrimidyl cyclopentanes as AKT protein kinase inhibitors